Daito Pharmaceutical Co Ltd
TSE:4577
Daito Pharmaceutical Co Ltd
EPS (Diluted)
Daito Pharmaceutical Co Ltd
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Daito Pharmaceutical Co Ltd
TSE:4577
|
EPS (Diluted)
¥142
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
1%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
EPS (Diluted)
¥131
|
CAGR 3-Years
-22%
|
CAGR 5-Years
73%
|
CAGR 10-Years
7%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
EPS (Diluted)
¥155
|
CAGR 3-Years
65%
|
CAGR 5-Years
19%
|
CAGR 10-Years
-10%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
EPS (Diluted)
¥633
|
CAGR 3-Years
40%
|
CAGR 5-Years
22%
|
CAGR 10-Years
9%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
EPS (Diluted)
¥249
|
CAGR 3-Years
2%
|
CAGR 5-Years
19%
|
CAGR 10-Years
24%
|
|
|
Astellas Pharma Inc
TSE:4503
|
EPS (Diluted)
¥28
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-7%
|
|
Daito Pharmaceutical Co Ltd
Glance View
Daito Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Toyama-Shi, Toyama-Ken and currently employs 846 full-time employees. The company went IPO on 2010-03-24. The pharmaceutical ingredients business is engaged in the manufacture, purchase, sale and entrusted manufacture business of pharmaceutical ingredients used as raw materials for pharmaceutical manufacture and formulation. The formulation business is engaged in the manufacture, purchase, sale and entrusted manufacture business of prescription pharmaceuticals and pharmaceuticals for general-use medicines.
See Also
What is Daito Pharmaceutical Co Ltd's EPS (Diluted)?
EPS (Diluted)
142.8
JPY
Based on the financial report for Feb 28, 2025, Daito Pharmaceutical Co Ltd's EPS (Diluted) amounts to 142.8 JPY.
What is Daito Pharmaceutical Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
1%
Over the last year, the EPS (Diluted) growth was -32%. The average annual EPS (Diluted) growth rates for Daito Pharmaceutical Co Ltd have been -24% over the past three years , -15% over the past five years , and 1% over the past ten years .
You don't have any saved screeners yet